RMRosa Mackay

Rosa Mackay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rosa Mackay has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Amrit Dhadda

    Affiliation Anaesthetic Department, Cardiff and Vale University Health Board, Cardiff, United Kingdom

    1 shared publication
  • Amy Elsmore

    Affiliations The Shrewsbury and Telford Hospitals NHS Trust, Telford, United Kingdom, School of Medicine, Keele University, Keele, United Kingdom

    1 shared publication
  • Annalucia Darbey

    MRC Centre for Reproductive Health University of Edinburgh, The Queen's Medical Research Institute Edinburgh UK

    1 shared publication
  • Anne-Louise Gannon

    College of Engineering, Science and Environment, The University of Newcastle , Callaghan, New South Wales 2308

    1 shared publication
  • Ayşe Gür Geden

    Affiliations Patient and Public Involvement (PPI) co-applicant UCL Institute of Education, London, United Kingdom

    1 shared publication
  • Ben M. Lawrence

    College of Engineering, Science and Environment, The University of Newcastle , Callaghan, New South Wales 2308

    1 shared publication

Latest Publications

  • Open Access

    Managing obstetric bleeding in Wales: A qualitative evaluation of the OBS Cymru care bundle using Normalisation Process Theory

    by Tanvi Rai, Lisa E. Hinton, Rosa Mackay, Mairead Black, Julia Sanders, Pauline Slade, Amy Elsmore, Amrit Dhadda, William Parry-Smith, Rachel Collis, et al.

    Background: Post-partum haemorrhage (PPH) is one of the leading causes of maternal mortality and morbidity worldwide. The Obstetric Bleeding Strategy (OBS) care bundle for PPH management was adopted into Welsh national guidelines in 2019 (as OBS Cymru), and is currently being implemented across 36 sites in the rest of the UK through the OBS UK stepped-wedge cluster randomised controlled trial. We conducted a qualitative evaluation of the OBS care bundle five years after its adoption to inform plans for optimising its implementation across the UK. Methods: We conducted ethnographic observations, informal conversations and qualitative interviews with multidisciplinary teams (MDT) in four maternity units in Wales. Data were analysed thematically and using Normalisation Process Theory. Results: The OBS Cymru protocol was used daily and MDT members believe it improves the quality and safety of PPH management. The paper proforma supporting OBS Cymru was the ‘boundary object’ that kept the care bundle in view while clarifying individualised roles across the MDT during a PPH and prompting improved and continuous communication as bleeding progressed. The standardisation of processes through the care bundle was seen as enabling all staff with an overall knowledge of PPH care, while situating the prominence of their particular roles within a greater whole. Enacting the bundle in practice varied slightly across different settings, according to staffing structures (e.g., in delivery rooms versus theatre births) and caseload, and some residual tensions remained regarding expectations from different staff members and levels of support provided regarding OBS Cymru. Conclusions: Despite some small-scale variations, OBS care bundle has become normalised as standard PPH care in Wales. Insights from this evaluation, such as the centrality of the proforma in holding the bundle together, and need for greater clarity in staff role expectations, have informed implementation plans for the OBS UK trial.


  • Open Access

    Compensatory mechanisms that maintain androgen production in mice lacking key androgen biosynthetic enzymes

    by Ben M. Lawrence, Liza O'DOnnell, Anne‐Louise Gannon, Sarah Smith, Michael K. Curley, Annalucia Darbey, Rosa Mackay, Peter J. O'SHaughnessy, Lee B. Smith, Diane Rebourcet

    Testosterone and dihydrotestosterone (DHT) are essential for male development and fertility. In the canonical androgen production pathway, testosterone is produced in the testis by HSD17B3; however, adult male Hsd17b3 knockout (KO) mice continue to produce androgens and are fertile, indicating compensatory mechanisms exist. A second, alternate pathway produces DHT from precursors other than testosterone via 5α‐reductase (SRD5A) activity. We hypothesized that the alternate pathway contributes to androgen bioactivity in Hsd17b3 KO mice. To investigate contributions arising from and interactions between the canonical and alternate pathways, we pharmacologically inhibited SRD5A and ablated Srd5a1 (the predominant SRD5A in the testis) on the background of Hsd17b3 KO mice. Mice with perturbation of either the canonical or both pathways exhibited increased LH, testicular steroidogenic enzyme expression, and normal reproductive tracts and fertility. In the circulation, alternate pathway steroids were increased in the absence of HSD17B3 but were reduced by co‐inhibition of SRD5A1. Mice with perturbations of both pathways produced normal basal levels of intratesticular testosterone, suggesting the action of other unidentified hydroxysteroid dehydrogenase(s). Strikingly, testicular expression of another SRD5A enzyme, Srd5a2 , was markedly increased in the absence of Hsd17b3 , suggesting a compensatory increase in SRD5A2 to maintain androgen bioactivity during HSD17B3 deficiency. Finally, we observed elevated circulating concentrations of the 11‐keto‐derivative of DHT, suggesting compensatory extra‐gonadal induction of bioactive 11‐keto androgen production. Taken together, we conclude that, in the absence of the canonical pathway of androgen production, multiple intra‐ and extra‐gonadal mechanisms cooperate to maintain testosterone and DHT production, supporting male development and fertility.